Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1

In part 1 of this 2-part podcast, a panel of experts discusses treatment goals in patients with interstitial lung disease (ILD) and reviews of treatment paradigms and standard of care therapies

Today we are bringing you part 1 of a 2-part sponsored podcast series discussing treatment goals in insterstitial lung disease (ILD). The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.

The topics of conversation for today’s podcast include treatment goals in patients with ILD and a review of treatment paradigms and standard of care therapies.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

© 2023 MJH Life Sciences
AJMC®
All rights reserved.